About Us

Vectura Fertin Pharma Laboratories is part of Vectura Fertin Pharma and provides contract end-to-end preclinical services with particular expertise in inhalation and aerosol sciences from it’s facility in Singapore. Combined with Vectura's market-leading inhaled CDMO services, we support customers achieve their goals to bring inhaled products to market.  

Our Vision

To be the preferred solution provider in preclinical research with a global reputation in improving human health through science and innovation.

Our Mission

To accelerate drug development by providing data-driven science to our clients to support clients' efforts to confidently achieve regulatory approval and sustainable growth.


Our Facility

A purpose built facility with state-of-the-art technologies

Located in Singapore, our 60,000 sq. ft. facility is fully equipped with state- of- the- art labs, including 17 animal rooms, an in-house aerosol lab, animal biosafety labs*, necropsy, histology, analytical and bioanalytical, cell biology, tissue culture and microbiology labs. The facility is fully capable of enabling timely analysis of your study endpoints, accelerating your “time to market” goals.

*Up to biosafety level 2 (ABSL2)


Our People

Working together to make your preclinical research goals a reality

At Vectura Fertin Pharma Laboratories, we practice diversity and inclusion in our workplace. We have an international mix of world-class scientists, engineers, technicians and staff who each brings along with them valuable experience, extensive knowledge and passion about the work they do. With extensive experience in general and inhalation toxicology, in-vitro toxicology, aerosol sciences and various disease models, we work together to make your preclinical research goals a reality. 


Our Accreditations

We are a GLP, AAALAC and ISO17025 certified test facility

Our life sciences QA team are committed in assuring that the rigorous quality requirements are met.

Vectura Fertin Pharma Laboratories is a GLP, AAALAC and ISO17025 accredited test facility and has been subjected to a rigorous annual inspection scheme under the national GLP compliance monitoring program since 2011. Our scope of GLP registration includes both in-vivo and in-vitro toxicology and genotoxicity studies. Non-clinical studies conducted in Vectura Fertin Pharma Laboratories are also performed in accordance with the OECD Principles of Good Laboratory Practice. As a full adherent member of the OECD Mutual Acceptance of Data Framework, data from studies conducted are also internationally recognized and accepted across key markets including the US, European and Asia Pacific markets. 

GLP: Good Laboratory Practice; AAALAC: Association for Assessment and Accreditation of Laboratory Animal Care; OECD: Organisation for Economic Co-Operation and Development; ISO17025 accreditation for chemical and biological testing, granted since 31 Jan 2023


Our Animals in Research

Our commitment to uphold the highest standards of animal welfare 

We strongly believe that good animal welfare equals good science, and our team upholds animal welfare standards in the highest regard. Our facility has been accredited by the International Association for Assessment and Accreditation of Laboratory Animal Care (AAALAC) since 2012, and adheres to local animal welfare guidelines and regulations*. All animal studies conducted at our facility are subject to approval from the Institutional Animal Care and Use Committee (IACUC). We follow the principles of the “3Rs” in animal research: Replace, Reduce, and Refine. At the heart of our animal care and use program is a dedicated and highly trained team of veterinary care staff supporting the Attending Veterinarian in ensuring the day-to-day welfare of all study animals.

*National Advisory Committee for Laboratory Animal Research [NACLAR] and Animal & Veterinary Service [AVS]